Recent studies have reported a high prevalence of psychiatric comorbidities in Ultra High
Risk (UHR) for psychosis populations. This study examined the prevalence of comorbidity and …

Although the Positive and Negative Syndrome Scale (PANSS) is widely utilized in
schizophrenia research, variability in specific item loading exist, hindering reproducibility and …

Introduction The Brief Negative Symptom Scale (BNSS) includes five domains of negative
symptoms suggested by the NIMH Consensus Development Conference (anhedonia, …

Background Early onset of mental disorders is a major social and public health concern as it
affects individuals in their most formative years. The impact is more pronounced when early …

Numerous studies have been published on the psychosis prodrome and have explored a
wide array of its many aspects. However, the set of risk factors identified by these various …

Introduction Clozapine use is associated with higher risks of metabolic side effects and
cardiovascular diseases (CVD). Thus, this study aims to establish and compare the …

The impact of cognitive impairments on the health-related quality of life (HRQoL) in individuals
with schizophrenia is unclear. The aim of this study was to examine the association …

There is a pressing need for reliable and valid rating scales to assess and measure depression
in individuals at ultra-high risk (UHR) of psychosis. The aim of this study was to examine …

Background: Both drug-induced Parkinsonism (DIP) and tardive dyskinesia (TD) have been
shown to be associated with lower health-related quality of life (HRQOL) in schizophrenia, …

Aim Recent studies have highlighted that attenuated psychotic symptoms ( APS ) are an
important source of distress in ultra high risk ( UHR ) individuals and that this distress is related …